We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MKS Instruments (MKSI) Divests Analytics Business for $72.5M
Read MoreHide Full Article
Premium Scientific & Technical Instruments company, MKS Instruments, Inc. (MKSI - Free Report) recently completed the divestiture of its Data Analytics Solutions business to the prominent biopharmaceutical supplier, Sartorius Stedim Biotech (Sartorius). We believe that the move is in sync with the company’s latest operating model.
MKS Instruments’ stock looks a safe investment bet at the moment. Over the last one year, shares of this Zacks Rank #2 (Buy) stock yielded a return of 81.06%, outperforming 49.22% growth recorded by the Zacks classified Electronics-Manufacturing Machinery industry. Also, the stock’s projected earnings per share (‘EPS’) growth for (F1/F0) and (F2/F1) is currently pegged at 28.05% and 8.51%, respectively.
Deal with Sartorius
Sartorius provides high-quality cutting-edge apparatus and services for manufacturing processes, quality assurance, and development of the global biopharmaceutical market. MKS Instruments’ divested its Data Analytics Solutions trade to Sartorius for $72.5 million, on a debt-free and cash basis. It is a software business of the company based in Malmo, Sweden.
MKS Data Analytics Solutions offers a premium solution to end users, named Umetrics Suite. The suit includes the company’s popular software platforms such as MODDE and SIMCA. These unique multivariate data analysis and modelling software are used by numerous pharmaceutical and biotechnology companies across the world.
Until Jan 13, 2016, MKS Data Analytics Solutions was known as MKS Umetrics. Notably, MKS Instruments had acquired Umetrics on Jan 3, 2006.
In 2016, MKS Data Analytics Solutions generated revenues worth $13 million.
Our Take
MKS Instruments is currently boosting its top- and bottom-line performance on the back of a renewed operating model. The company is making new investments in certain specific end markets (like semiconductor) witnessing robust demand. In order to fund these investments, the company has been strategically reducing interest expenses and deleveraging its balance sheet. In addition, we believe that the above mentioned sale of the analytics business is likely to improve MKS Instruments’ liquidity in the near term.
Other Stocks to Consider
Some other well-ranked stocks within the industry are listed below:
Analog Devices, Inc. (ADI - Free Report) boasts a Zacks Rank #1 and has a positive average earnings surprise of 14.14% for the trailing four quarters.
Adobe Systems Incorporated (ADBE - Free Report) presently holds a Zacks Rank #2 (Buy) and has a positive average earnings surprise of 7.71% for the last four quarters.
Zacks’ Best Private Investment Ideas
In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time?
Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Click here for Zacks' private trades >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
MKS Instruments (MKSI) Divests Analytics Business for $72.5M
Premium Scientific & Technical Instruments company, MKS Instruments, Inc. (MKSI - Free Report) recently completed the divestiture of its Data Analytics Solutions business to the prominent biopharmaceutical supplier, Sartorius Stedim Biotech (Sartorius). We believe that the move is in sync with the company’s latest operating model.
MKS Instruments’ stock looks a safe investment bet at the moment. Over the last one year, shares of this Zacks Rank #2 (Buy) stock yielded a return of 81.06%, outperforming 49.22% growth recorded by the Zacks classified Electronics-Manufacturing Machinery industry. Also, the stock’s projected earnings per share (‘EPS’) growth for (F1/F0) and (F2/F1) is currently pegged at 28.05% and 8.51%, respectively.
Deal with Sartorius
Sartorius provides high-quality cutting-edge apparatus and services for manufacturing processes, quality assurance, and development of the global biopharmaceutical market. MKS Instruments’ divested its Data Analytics Solutions trade to Sartorius for $72.5 million, on a debt-free and cash basis. It is a software business of the company based in Malmo, Sweden.
MKS Data Analytics Solutions offers a premium solution to end users, named Umetrics Suite. The suit includes the company’s popular software platforms such as MODDE and SIMCA. These unique multivariate data analysis and modelling software are used by numerous pharmaceutical and biotechnology companies across the world.
Until Jan 13, 2016, MKS Data Analytics Solutions was known as MKS Umetrics. Notably, MKS Instruments had acquired Umetrics on Jan 3, 2006.
In 2016, MKS Data Analytics Solutions generated revenues worth $13 million.
Our Take
MKS Instruments is currently boosting its top- and bottom-line performance on the back of a renewed operating model. The company is making new investments in certain specific end markets (like semiconductor) witnessing robust demand. In order to fund these investments, the company has been strategically reducing interest expenses and deleveraging its balance sheet. In addition, we believe that the above mentioned sale of the analytics business is likely to improve MKS Instruments’ liquidity in the near term.
Other Stocks to Consider
Some other well-ranked stocks within the industry are listed below:
Applied Optoelectronics, Inc. (AAOI - Free Report) has a remarkable positive average earnings surprise of 116.49% for the past four quarters and currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Analog Devices, Inc. (ADI - Free Report) boasts a Zacks Rank #1 and has a positive average earnings surprise of 14.14% for the trailing four quarters.
Adobe Systems Incorporated (ADBE - Free Report) presently holds a Zacks Rank #2 (Buy) and has a positive average earnings surprise of 7.71% for the last four quarters.
Zacks’ Best Private Investment Ideas
In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time?
Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Click here for Zacks' private trades >>